Torticollis Clinical Trials

Find Torticollis Clinical Trials Near You

The Effect of Noninvasive Brain Stimulation on Symptoms of Cervical Dystonia

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The primary aim of this study is to assess whether continuous theta-burst stimulation (cTBS) can be helpful in reducing symptoms of idiopathic cervical dystonia. This will be a parallel-group, randomised, sham-controlled, double blind clinical trial. Patients and investigators measuring patient symptoms clinical scales will be blinded from allocation group, investigators delivering the intervention will not be blinded, as this is not feasible. Real cTBS will be compared to sham cTBS, with patients allocated to these two groups with a 1:1 recruitment ratio. Bilateral cTBS will be delivered four times daily, over eight days, for a total of 32 bilateral cTBS sessions. The primary outcome is the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS). This will be administered at T1 (pre-cTBS), T2 (day 10, following days 2-9 where patients received the intervention), T3 (2 weeks post the final session of cTBS), and T4 (4-5 weeks post the final session of cTBS). Secondary outcomes will be the TWSTRS subscales (severity, disability, pain), Quality of Life scale, Global dystonia severity rating scale (GDS), Fahn Tolosa Marin (FTM) modified (to include only questions relevant to head/neck tremor) tremor scale, kinematic data of patient's movement patterns, motor evoked potentials (MEPs), and resting-state fMRI data (fMRI).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:

• Aged between 18 and 85 years

• Diagnosis of idiopathic cervical dystonia made by an expert physician

• Last botulinum toxin injection administered at least two months before the start of participation in the study (Albanese, Abbruzzese et al. 2015)

Locations
Other Locations
Italy
Università Campus Bio-Medico
RECRUITING
Roma
Contact Information
Primary
Daniel T Corp, PhD
danieltcorp@gmail.com
+393445660971
Backup
Ambra Salvati
ambra.salvati@unicampus.it
+393491028595
Time Frame
Start Date: 2026-07-06
Estimated Completion Date: 2028-05-06
Participants
Target number of participants: 26
Treatments
Experimental: Active cTBS
The patients of this group will receive 4 sessions of bilateral somatosensory cortex cTBS per day for 8 days
Sham_comparator: Sham cTBS
The patients of this group will receive 4 sessions of bilateral somatosensory cortex cTBS per day for 8 days, delivered using a sham TMS coil.
Sponsors
Leads: Fondazione Policlinico Universitario Campus Bio-Medico
Collaborators: European Commission

This content was sourced from clinicaltrials.gov